Literature DB >> 8325035

Typical and atypical natural history of IgA nephropathy in adult patients.

G D'Amico1, A Ragni, E Gandini, G Fellin.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8325035     DOI： 10.1159/000422389

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  8 in total

1.  Treatment for IgA nephropathy with stage 3 or 4 chronic kidney disease: low-dose corticosteroids combined with oral cyclophosphamide.

Authors:  Feng Ma; Xiaoxia Yang; Meilan Zhou; Ming Bai; Lijuan Zhao; Li Li; Ruijuan Dong; Chunmei Liu; Rong Li; Shiren Sun
Journal:  J Nephrol       Date:  2020-05-23       Impact factor: 3.902

Review 2.  Treatment of IgA nephropathy and Henoch-Schönlein nephritis.

Authors:  Jürgen Floege; John Feehally
Journal:  Nat Rev Nephrol       Date:  2013-04-02       Impact factor: 28.314

3.  Histopathologic features aid in predicting risk for progression of IgA nephropathy.

Authors:  Michael Walsh; Aylin Sar; Diane Lee; Serdar Yilmaz; Hallgrimur Benediktsson; Braden Manns; Brenda Hemmelgarn
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

4.  alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.

Authors:  Mara Ferrandi; Daniele Cusi; Isabella Molinari; Lucia Del Vecchio; Cristina Barlassina; Maria Pia Rastaldi; Francesco Paolo Schena; Fabio Macciardi; Carmelita Marcantoni; Dario Roccatello; Luanne L Peters; Silvia Armelloni; Li Min; Laura Giardino; Deborah Mattinzoli; Claudio Camisasca; Fiorentina Palazzo; Paolo Manunta; Patrizia Ferrari; Giuseppe Bianchi
Journal:  J Mol Med (Berl)       Date:  2009-10-17       Impact factor: 4.599

Review 5.  Treatment of IgA nephropathy with renal insufficiency.

Authors:  Claudio Pozzi; Cristina Sarcina; Francesca Ferrario
Journal:  J Nephrol       Date:  2016-01-07       Impact factor: 3.902

6.  The size of palatine tonsils cannot be used to decide the indication of tonsillectomy for IgA nephropathy.

Authors:  Mitsuhiro Sato; Mika Adachi; Hideyuki Kosukegawa; Yuri Nomura; Kenichi Watanabe; Toshinobu Sato; Yoshio Taguma
Journal:  Clin Kidney J       Date:  2017-01-21

7.  Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study.

Authors:  Qing Jia; Feng Ma; Jin Zhao; Xiaoxia Yang; Ruiling Sun; Rong Li; Shiren Sun
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

8.  Corticosteroids in patients with IgA nephropathy and severe chronic renal damage.

Authors:  Claudio Pozzi; Francesca Ferrario; Bianca Visciano; Lucia Del Vecchio
Journal:  Case Rep Nephrol       Date:  2012-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.